[{"address1": "828 Winter Street", "address2": "Suite 300", "city": "Waltham", "state": "MA", "zip": "02451", "country": "United States", "phone": "857 524 2466", "website": "https://xiliotx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Xilio Therapeutics, Inc., a clinical-stage biotechnology company, engages in the discovery and development of tumor-activated immuno-oncology therapies. The company's checkpoint inhibitor program includes XTX101, an investigational Fc-enhanced, tumor-activated anti-CTLA-4 mAb that is in Phase 2 clinical trial for patients with advanced solid tumors. It also develops cytokine programs, which comprises XTX202, a tumor-activated beta-gamma biased IL-2, currently under Phase 2 clinal trials; and XTX301, an investigational tumor-activated, engineered IL-12 molecule, currently under Phase 1 studies. The company was founded in 2016 and is headquartered in Waltham, Massachusetts.", "fullTimeEmployees": 73, "companyOfficers": [{"maxAge": 1, "name": "Dr. Rene  Russo BCPS, Pharm.D.", "age": 49, "title": "President, CEO & Director", "yearBorn": 1975, "fiscalYear": 2023, "totalPay": 875130, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Christopher  Frankenfield", "age": 42, "title": "Chief Operating Officer", "yearBorn": 1982, "fiscalYear": 2023, "totalPay": 704848, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Katarina  Luptakova M.D.", "age": 48, "title": "Chief Medical Officer", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 591917, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kevin M. Brennan", "age": 54, "title": "Senior VP of Finance & Accounting", "yearBorn": 1970, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Uli  Bialucha Ph.D.", "title": "Chief Scientific Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Caroline  Hensley", "title": "Chief Legal Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Scott  Coleman Ph.D.", "title": "Chief Development Officer", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.9327, "open": 0.9357, "dayLow": 0.8521, "dayHigh": 0.9595, "regularMarketPreviousClose": 0.9327, "regularMarketOpen": 0.9357, "regularMarketDayLow": 0.8521, "regularMarketDayHigh": 0.9595, "payoutRatio": 0.0, "beta": -0.342, "forwardPE": -1.5663794, "volume": 580056, "regularMarketVolume": 580056, "averageVolume": 4179433, "averageVolume10days": 1164090, "averageDailyVolume10Day": 1164090, "bid": 0.8691, "ask": 0.964, "bidSize": 11, "askSize": 11, "marketCap": 45484872, "fiftyTwoWeekLow": 0.58, "fiftyTwoWeekHigh": 1.93, "priceToSalesTrailing12Months": 9.84521, "fiftyDayAverage": 0.95746, "twoHundredDayAverage": 0.94546, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -12908090, "profitMargins": 0.0, "floatShares": 15328620, "sharesOutstanding": 50065900, "sharesShort": 1810353, "sharesShortPriorMonth": 213071, "sharesShortPreviousMonthDate": 1736899200, "dateShortInterest": 1739491200, "sharesPercentSharesOut": 0.036199998, "heldPercentInsiders": 0.29229, "heldPercentInstitutions": 0.47256002, "shortRatio": 0.21, "shortPercentOfFloat": 0.042600002, "impliedSharesOutstanding": 50065900, "bookValue": 0.477, "priceToBook": 1.9046122, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -62803000, "trailingEps": -1.55, "forwardEps": -0.58, "enterpriseToRevenue": -2.794, "enterpriseToEbitda": 0.207, "52WeekChange": 0.23249674, "SandP52WeekChange": 0.121255875, "quoteType": "EQUITY", "currentPrice": 0.9085, "targetHighPrice": 5.0, "targetLowPrice": 4.0, "targetMeanPrice": 4.5, "targetMedianPrice": 4.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 61259000, "totalCashPerShare": 1.394, "ebitda": -62428000, "totalDebt": 8415000, "quickRatio": 1.611, "currentRatio": 1.665, "totalRevenue": 4620000, "debtToEquity": 40.121, "revenuePerShare": 0.104, "returnOnAssets": -0.52579, "returnOnEquity": -1.70958, "grossProfits": 4620000, "freeCashflow": -3042250, "operatingCashflow": -17648000, "grossMargins": 1.0, "ebitdaMargins": 0.0, "operatingMargins": -6.5413203, "financialCurrency": "USD", "symbol": "XLO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "regularMarketChangePercent": -2.5946138, "regularMarketPrice": 0.9085, "marketState": "CLOSED", "corporateActions": [], "postMarketTime": 1741390730, "regularMarketTime": 1741381201, "exchange": "NMS", "messageBoardId": "finmb_365333564", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "shortName": "Xilio Therapeutics, Inc.", "longName": "Xilio Therapeutics, Inc.", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1634909400000, "postMarketChangePercent": 1.80517, "postMarketPrice": 0.9249, "postMarketChange": 0.0164, "regularMarketChange": -0.024199963, "regularMarketDayRange": "0.8521 - 0.9595", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 4179433, "fiftyTwoWeekLowChange": 0.32850003, "fiftyTwoWeekLowChangePercent": 0.56637937, "fiftyTwoWeekRange": "0.58 - 1.93", "fiftyTwoWeekHighChange": -1.0214999, "fiftyTwoWeekHighChangePercent": -0.5292746, "fiftyTwoWeekChangePercent": 23.249674, "earningsTimestampStart": 1743507000, "earningsTimestampEnd": 1743939000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -1.55, "epsForward": -0.58, "epsCurrentYear": -1.21, "priceEpsCurrentYear": -0.7508264, "fiftyDayAverageChange": -0.04895997, "fiftyDayAverageChangePercent": -0.051135264, "twoHundredDayAverageChange": -0.036960006, "twoHundredDayAverageChangePercent": -0.039092086, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-22", "cryptoTradeable": false, "displayName": "Xilio Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-03-08"}]